SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-134300
Filing Date
2020-12-10
Accepted
2020-12-10 18:15:59
Documents
1
Period of Report
2020-12-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2037869-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2037869-2_4seq1.xml 4 6182
  Complete submission text file 0001104659-20-134300.txt   7563
Mailing Address C/O BIOVERATIV INC. 225 SECOND AVENUE WALTHAM MA 02451
Business Address
Cox John (Reporting) CIK: 0001498428 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39746 | Film No.: 201381679

Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Issuer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations